With the analysis among 344 patents, we discovered top 83 key players by total patent application. Alcon AG, Novartis AG, Alcon Laboratories, Inc. are dominant in this area. They take 37.79% of the total patent filing.
Basel-Stadt, Switzerland
Patent: 37
Texas, United States
Patent: 22
New York, United States
Patent: 14
California, United States
Patent: 13
Taiwan Liposome Co., Ltd.
Taiwan Province, China
Patent: 11
West Virginia, United States
Patent: 11
TLC Biopharmaceuticals, Inc.
California, United States
Patent: 11
Senju Pharmaceutical Beijing Co. Ltd.
Beijing Shi, China
Patent: 10
With the analysis among 4 patents, we discovered top 4 start-ups by total patent application. Eyevance Pharmaceuticals LLC, Surface Ophthalmics, Inc., IVIEW Therapeutics, Inc. are active in this area.
Eyevance Pharmaceuticals LLC
Texas, United States
Patent: 1
Surface Ophthalmics, Inc.
California, United States
Patent: 1
Pennsylvania, United States
Patent: 1
California, United States
Patent: 1
With the analysis among related 34 patents applied in the last 5 years. We discover 23 most active companies in this area. The fast-growing TLC Biopharmaceuticals, Inc., Taiwan Liposome Co., Ltd., Shenyang Sinqi Ophthalmic Medications Holdings Co., Ltd. take 17.65% of patent filing during this period.
TLC Biopharmaceuticals, Inc.
California, United States
Patent: 2
Taiwan Liposome Co., Ltd.
Taiwan Province, China
Patent: 2
Shenyang Sinqi Ophthalmic Medications Holdings Co., Ltd.
Liaoning Sheng, China
Patent: 2
Dongguk University Industry-Academic Cooperation Foundation
Gyeongsangbuk-do, South Korea
Patent: 2
Chengdu Ruimu Biomedical Technology Co., Ltd.
Sichuan Sheng, China
Patent: 2
Taiwan Province, China
Patent: 2
California, United States
Patent: 1
HANALL BIOPHARMA Co., Ltd.
Surface Ophthalmics, Inc.
California, United States
Patent: 1
Guoda Healthcare (Xiamen) Technology Co., Ltd
Fujian Sheng, China
Patent: 1
With the analysis among related 34 patents in last 5 years, we discover 15 new entrants. Shenyang Sinqi Ophthalmic Medications Holdings Co., Ltd., Dongguk University Industry-Academic Cooperation Foundation, Chengdu Ruimu Biomedical Technology Co., Ltd. are the most active new entrants in this area.
Shenyang Sinqi Ophthalmic Medications Holdings Co., Ltd.
Liaoning Sheng, China
Patent: 2
Dongguk University Industry-Academic Cooperation Foundation
Gyeongsangbuk-do, South Korea
Patent: 2
Chengdu Ruimu Biomedical Technology Co., Ltd.
Sichuan Sheng, China
Patent: 2
Taiwan Province, China
Patent: 2
California, United States
Patent: 1
HANALL BIOPHARMA Co., Ltd.
Surface Ophthalmics, Inc.
California, United States
Patent: 1
Guoda Healthcare (Xiamen) Technology Co., Ltd
Fujian Sheng, China
Patent: 1
Pennsylvania, United States
Patent: 1
Seinda Pharmaceutical Corp
Guangdong Sheng, China
Patent: 1
With the analysis among 34 patents, we discovered top 8 universities and scientific research institutions by total patent application. Duke University, Nagoya City University, University of Houston are dominant in this area. They take 38.24% of the total patent filing.
North Carolina, United States
Patent: 6
Aichi-ken, Japan
Patent: 4
Texas, United States
Patent: 3
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 2
University of Kansas Medical Center
Shanghai Shi, China
Patent: 1
China Three Gorges University
Hubei Sheng, China
Patent: 1
Jiangsu Sheng, China
Patent: 1